Reporter Sept 19 2014
Sep. 18, 2014—Schizophrenia and bipolar disorder share common genetic underpinnings. Vanderbilt researchers combined high-resolution gene expression studies with gene association data to reveal signaling pathways linked to schizophrenia and bipolar disorder.
Sep. 18, 2014—Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients.
Sep. 18, 2014—Imagine an inherited cause of early heart attacks that is more common than type-1 diabetes, multiple sclerosis or cystic fibrosis, but goes largely unrecognized.
Sep. 18, 2014—The Tennessee Public Health Association and the Tennessee Medical Association are collaborating to establish the “William Schaffner, M.D., Public Health Hero Award,” to be presented annually to an individual who has demonstrated extraordinary efforts in the advancement of public health in Tennessee.
Sep. 18, 2014—Vanderbilt University Medical Center will host representatives from the country’s leading medical schools next week to discuss one of the American Medical Association’s (AMA) top initiatives — accelerating change in medical education.
Sep. 18, 2014—Bernard Lo, M.D., president of the Greenwall Foundation and director emeritus of the Program in Medical Ethics at the University of California, San Francisco, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 25.
Sep. 18, 2014—Vanderbilt University School of Nursing’s Jennifer Kim, MSN, received the 2014 Excellence in Leadership award from the Gerontological Advanced Practice Nurses Association at the group’s recent national conference in Orlando, Florida.
Sep. 18, 2014—Richard Latuska, a third-year student at Vanderbilt University School of Medicine, was elected to the National Alpha Omega Alpha (AOA) Honor Medical Society as a student director.
Sep. 18, 2014—Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.